Importantly, AMPK activation can lead to inhibition of cell proliferation when cardiomyocytes and vascular smooth muscle cells (VSMCs) are in a state of ischemia and hypoxia, thus playing an important role in the regulation of cardiovascular diseases and in the prevention and treatment of atherosclerosis (Yan et al., 2018). Here, PRKAA2 is linked to atherosclerosis.